CERES INC COM USD0.01..............

Glat is currently a principal of Glat & Associates, an agribusiness consultancy firm in Rio Grande do Sul, Brazil. He previously spent 25 years working for Pioneer Hi-Bred International, Inc., a Dupont business, including 21 years in Brazil. From August 2007 to June 2011, he served as the director for international operations, where he was responsible for Pioneer's activities in Latin America, Africa and Asia. During this time he also served on the board of directors of Pioneer. From January 1998 to August 2007, Glat was president of the Pioneer's Brazilian subsidiary, Pioneer Sementes Ltda., having previously held various sales, marketing and business leadership roles at the subsidiary. Glat currently owns a 900-hectare farming operation in the Brazilian state of Tocatins. He received his B.S. and M.S. in Agronomy and Plant Genetics from the University of Arizona.

ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres' views as of any date subsequent to the date of this press release.
www.ceres.net/News/NewsReleases/2013/06-20-13-News-Rel.html

Due in part to the variability of this season's yields, the company anticipates that many of its mill customers will repeat smaller scale commercial plantings before committing to broad, large-scale adoption. "As a result, we expect total sweet sorghum seed sales next season to grow more modestly than originally anticipated," said Hamilton.

Ceres Chief Financial Officer Paul Kuc noted that the company continues to prioritize investments in its sorghum pipeline and its opportunity in Brazil, while closely monitoring its working capital levels. "As we move forward, we intend to maintain the strength of our balance sheet with these priorities in mind," he said.

THIRD QUARTER BUSINESS HIGHLIGHTS

•Based on customer reports, Ceres' portfolio of sweet sorghum hybrids has outyielded competing products this season at multiple locations where side-by-side comparisons were available.
•For mills that reported results, ethanol yields from Ceres products ranged from approximately 450 to 3,600 liters per hectare, according to customer and company calculations. Mills representing the top 20% of yields, and which generally followed established crop management practices, achieved average yields ranging from 2,100 to 3,300 liters per hectare. Lower yields were primarily due to deviations from recommended crop management practices, weather-related delays during planting and disease infection late in the growing season. Yield results were available from approximately two-thirds of the mills that planted Ceres' hybrids; remaining mills reported incomplete results, did not complete the evaluation or chose not to report results.
•Ceres has completed field trials required to register more than 10 new sweet sorghum hybrids with the Brazilian government. The company plans to begin commercial evaluations of the first of these products during the upcoming 2013-2014 growing season.
•The company plans to evaluate hundreds of pre-commercial and experimental hybrids in Brazil next season, with dozens included in field evaluations at multiple locations. These cultivars have demonstrated higher yields, better adaptation to certain environmental conditions and other performance improvements over existing products in initial field evaluations.
THIRD QUARTER FINANCIAL RESULTS

Total revenues for the quarter ended May 31, 2013 were $1.4 million compared to $1.1 million for the same period last year. The increase was due to higher product sales of $0.4 million, which consisted primarily of biomass sales as well as recognition of deferred revenue related to certain sales incentive and promotional programs during the 2012-2013 growing season in Brazil. The increase was partially offset by reduced billings of $0.1 million under the company's various grants and collaborations.

Cost of product sales was $2.1 million for quarter ended May 31, 2013 compared to $0.6 million for the same period last year. The increase was due to expenses of $1.0 million for crop management services performed under the company's sales incentive and promotional programs in Brazil, and $0.5 million for obsolete seed inventory relating to the company's sweet sorghum products.

Research and development expenses decreased by $1.2 million to $4.1 million for the quarter ended May 31, 2013 from $5.3 million for the same period last year. The decrease was primarily due to reduced personnel and related expenses as well as reduced external R&D expenses.

Selling, general and administrative expenses were $4.5 million for the quarter ended May 31, 2013 compared to $3.3 million for the same period last year. The increase was primarily due to higher expenses related to expanded business operations and market development support in Brazil, which was partially offset by reduced patent, legal and professional fees in the U.S.

For the quarter ended May 31, 2013, Ceres reported a net loss of $9.3 million, or $0.38 per share, compared to a net loss of $8.4 million, or $0.34 per share, for the quarter ended May 31, 2012.

At May 31, 2013, cash and cash equivalents and marketable securities totaled $37.4 million.

CONFERENCE CALL AND WEBCAST INFORMATION

Ceres has scheduled a conference call for 4:30 p.m. EDT (1:30 p.m. PDT) today to discuss third quarter results. The webcast of the conference call may be accessed at investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers:
(877) 838-4153

International callers:
+1 (720) 545-0037

An audio replay of the call will be available two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

UPCOMING EVENTS

Ceres is scheduled to present at the Jefferies Global Industrials Conference on August 12, 2013 in New York City as well as at the Advanced Biofuels Leadership Conference to be held October 9 to 11, 2013 in San Francisco, Calif. The company's slide presentations will be posted on the investor events page of the company's website, www.ceres.net.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres' views as of any date subsequent to the date of this press release.

 
CERES, INC. AND SUBSIDIARY
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
 
      Three Months Ended       Nine Months Ended
   May 31,    May 31,
   2013       2012    2013       2012
                 
Revenues:                
Product sales    $ 389     $ 42     $ 462     $ 429  
Collaborative research and government grants      966        1,106        3,884        3,778  
Total revenues      1,355        1,148        4,346        4,207  
Cost and operating expenses:                
Cost of product sales     2,134      627      5,114      1,876  
Research and development     4,074      5,255      12,784      15,522  
Selling, general and administrative      4,464        3,344        11,700         8,962  
Total cost and operating expenses      10,672        9,226        29,598        26,360  
Loss from operations     (9,317 )     (8,078 )     (25,252 )     (22,153 )
Interest expense     (34 )     (341 )     (35 )      (559 )
Interest income     28      3      106      9  
Other income (expense)      —        —        —        (84 )
Loss before income taxes     (9,323 )     (8,416 )     (25,181 )     (22,787 )
Income tax benefit (expense)      —        —        (1 )      (1 )
Net loss    $ (9,323 )    $ (8,416 )    $ (25,182 )    $ (22,788 )
Basic and diluted net loss per share attributable to
common stockholders
   $ (0.38 )    $ (0.34 )    $ (1.02 )    $ (2.33 )
Basic and diluted weighted average outstanding
common shares used for net loss per share
    24,801,705
     24,423,042
     24,765,664
     9,787,652
 
 
CERES, INC. AND SUBSIDIARY
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
(Unaudited)
 
      May 31,       August 31,
   2013    2012
         
Assets        
Current assets:        
Cash and cash equivalents    $ 18,821     $ 21,069  
Marketable securities     18,554      33,565  
Prepaid expenses     1,027      1,050  
Accounts receivable     848      765  
Inventories     352      841  
Other current assets      232        278  
Total current assets     39,834      57,568  
Property and equipment, net     4,915      5,756  
Marketable securities     —      5,720  
Other assets      108        203  
Total assets    $ 44,857      $ 69,247  
         
Liabilities and Stockholders' Equity        
Current liabilities:        
Accounts payable and accrued expenses    $ 4,899     $ 5,476  
Other current liabilities     26      732  
Current portion of long-term debt      84        134  
Total current liabilities     5,009      6,342  
Other non-current liabilities     97      88  
Long-term debt, net of current portion      130        256  
Total liabilities      5,236        6,686  
Commitments and contingencies        
Stockholders' equity:        
Common stock and additional paid in capital, $0.01 par value; 490,000,000 shares
authorized; 24,800,624 shares issued and outstanding at May 31, 2013; 24,549,029
shares issued and outstanding at August 31, 2012
    307,448      304,917  
Accumulated other comprehensive loss     (572 )     (283 )
Accumulated deficit      (267,255 )      (242,073 )
Total stockholders' equity      39,621        62,561  
Total liabilities and stockholders' equity    $ 44,857       $ 69,247  



Ceres, Inc.
Gary Koppenjan
Investors 805-375-7801
ir@ceres.net

Source: Ceres, Inc.


News Provided by Acquire Media
investor.ceres.net/releasedetail.cfm?ReleaseID=776566

Sweet sorghum is a hardy crop that can extend the ethanol production season by up to 60 days in Brazil. It can be grown on fallow sugarcane land and processed using the same equipment. Since it grows in as few as 90 to 120 days, it requires less water and other inputs than sugarcane. Ceres' sweet sorghum products were planted on more than 3,000 hectares this past season, with more than 30 mills. Grown primarily for its biomass productivity rather than sugar content, high biomass sorghum is an energy crop that can be used as feedstock for biopower, such as heat and electricity.

ABOUT CERES

Ceres, Inc. (www.ceres.net) is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

ABOUT SYNGENTA

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our mission: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, short-term and long-term business strategies, market and industry expectations and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres' views as of any date subsequent to the date of this press release.

SYNGENTA FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This press release does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Ceres Announces Webcast of Fiscal Year 2013 Financial Results

15:05 14.11.13

PR Newswire

THOUSAND OAKS, Calif., Nov. 14, 2013

THOUSAND OAKS, Calif., Nov. 14, 2013 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced that it will report financial results for fiscal year 2013 on Thursday, November 21, 2013 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EST (1:30 p.m. PST) to discuss its fiscal year-end results and to provide an update on its business.

Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers:

(877) 838-4153

International callers:

+1 (720) 545-0037

An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

SOURCE Ceres, Inc.
Quelle: PR Newswire

Ceres Announces Webcast of Fiscal First Quarter 2014 Financial Results
22:10 03.01.14

PR Newswire

THOUSAND OAKS, Calif., Jan. 3, 2014

THOUSAND OAKS, Calif., Jan. 3, 2014 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced that it will report financial results for first quarter of fiscal year 2014 on Thursday, January 9, 2014 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EST (1:30 p.m. PST) to discuss its fiscal first quarter results and to provide an update on its business.

Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers:

(877) 838-4153

International callers:

+1 (720) 545-0037

An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

SOURCE Ceres, Inc.


Quelle: PR Newswire

       200          §
  15:50:15§1,46 $
       100          §
  15:50:15§1,46 $
     3.900          §
  15:50:15§1,45 $
       200          §
  15:32:04§1,46 $
       100          §
  15:31:07§1,441 $
     3.500          §
  15:30:00§1,44 $
682

Kosmonova buran

03:50 05.03.14

PR Newswire

THOUSAND OAKS, Calif., March 4, 2014

THOUSAND OAKS, Calif., March 4, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the pricing of an underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. Ceres also granted the underwriters a 45-day option to purchase up to 3,000,000 additional shares of common stock to cover over-allotments, if any. Ceres expects to receive approximately $20 million in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the company. Ceres intends to use the net proceeds from this offering for general corporate purposes, including working capital.

The offering is expected to close on or about March 10, 2014, subject to the satisfaction of customary closing conditions.

Aegis Capital Corp is acting as sole book-running manager for the offering.

Trout Capital LLC acted as financial advisor to Ceres.

A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' public offering and its anticipated closing date, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Ceres Announces Full Exercise of Underwriter's Option to Purchase Additional Shares14:05 07.03.14


PR Newswire

THOUSAND OAKS, Calif., March 7, 2014


THOUSAND OAKS, Calif., March 7, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced the full exercise of the over-allotment option granted to the underwriter to purchase an additional 3,000,000 shares of common stock at a public offering price of $1.00 per share, in connection with the company's recently announced underwritten public offering of 20,000,000 common shares. The full exercise of the option brings total gross proceeds from the offering to $23,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the company.

The offering is expected to close on or about March 10, 2014, subject to the satisfaction of customary closing conditions.

Aegis Capital Corp is acting as sole book-running manager for the offering.

Trout Capital LLC is acting as financial advisor to Ceres.


A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' public offering and its anticipated closing date, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

17:00 10.03.14


PR Newswire

THOUSAND OAKS, Calif., March 10, 2014

THOUSAND OAKS, Calif., March 10, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, announced today the closing of its previously announced underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. In connection with this offering, the underwriter exercised in full its option to purchase an additional 3,000,000 shares of common stock from the company. Total gross proceeds from the offering were $23,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by the company.

Aegis Capital Corp acted as sole book-running manager for the offering.

Trout Capital LLC acted as financial advisor to Ceres.

A registration statement on Form S-1 relating to this offering was declared effective by the U.S. Securities and Exchange Commission on March 4, 2014. This offering is being made solely by means of a written prospectus forming part of the effective registration statement relating to these securities. Copies of the prospectus relating to this offering may be obtained by contacting Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY 10019, telephone: (212) 813-1010, e-mail: prospectus@aegiscap.com. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

2014 Financial Results
22:05 03.04.14

PR Newswire

THOUSAND OAKS, Calif., April 3, 2014

THOUSAND OAKS, Calif., April 3, 2014 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology and seed company, today announced that it will report financial results for the second quarter of fiscal year 2014 on Thursday, April 10, 2014 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EDT (1:30 p.m. PDT) to discuss its fiscal second quarter results and to provide an update on its business.

Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers:

(877) 838-4153

International callers:

+1 (720) 545-0037

An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

ABOUT CERES

Ceres, Inc. (www.ceres.net) is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

Logo - photos.prnewswire.com/prnh/20140509/86224

SOURCE Ceres, Inc.


Quelle: PR Newswire

"The timing of the rainfall has proved as important as the overall volume of water," said Richard Hamilton, Ceres President and CEO. He noted that generally favorable conditions during the beginning and end of the growing season have had a positive impact on plant growth. "Based on estimates from our agronomists, we have a high degree of confidence in our high biomass sorghum types at this point, and look forward to getting final yields of these products," he said. Ethanol yields for Ceres' sweet sorghum hybrids will not be known until harvests are completed and ethanol yields can be calculated.

In addition to its customer evaluations, Ceres has a number of new sorghum hybrids moving forward in its product development pipeline. "We are optimistic that even under adverse weather conditions we will be able to demonstrate ongoing performance improvements across our high biomass and sweet sorghum product pipelines," said Hamilton.

Ceres expects to collect performance data on its sorghum hybrids from more than 40 sites in south central Brazil. This data will be used to guide hybrid selections and planting decisions for the next season of mill evaluations, which begins in November. Ceres estimates that the high biomass sorghum and sweet sorghum market opportunities in Brazil are approximately one million hectares (2.4 million acres) each.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Dr. Jakob de Vlieg, Head of the Computational Life Sciences group at Bayer CropScience said, "Our company will benefit from implementing this integrated solution, as this platform is allowing interactive querying and integrated visualization of various omics data. The Persephone genome browser impressed both our geneticists and bioinformaticians with its performance and user friendly interface. Persephone will allow them to make decisions on experimental approaches."

Tim Swaller, Ceres' Vice President of Genomics Technologies, noted that speed is taken for granted across most software markets, but the genetics market has struggled with massive datasets generated by DNA sequencing and genetic testing. For instance, a typical genome contains multiple terabytes of data. Plant genomes, which can be larger than the human genome, have been some of the most challenging.

To help solve the speed problem, and expand the way researchers can explore and mine genetic data, Persephone software engineers have developed a number of proprietary data-compression methods and other optimizations. "The speed itself changes the way researchers can use their data. It encourages more exploratory research and better utilization of genetic data," said Swaller. Ceres has used Persephone in its marker-assisted breeding and biotech trait pipelines to speed the development of elite parental breeding lines and improved sorghum hybrids for Brazil.

Swaller said that Persephone can be deployed across a number of life science technology platforms that utilize genetic data. Ceres currently offers Persephone as a client-server installation and is developing a Software as a Service (SaaS) model that is intended to provide individual researchers with an online tool to visualize and compare genetic information stored in public databases. The company has targeted the deployment of a cloud-based beta version of Persephone by the end of this year.

"We believe there is a large number of individual researchers currently that could benefit from the Persephone interface," Swaller said. He noted that Ceres is also exploring opportunities for the software outside of the plant sciences.

About Persephone

Persephone is a genome visualization application marketed by Ceres, Inc. The software allows researchers to explore DNA databases in much the same way online mapping programs allow users to explore geographic regions and places. Persephone has been designed to display diverse data such as genetic maps, genomic sequences, gene models, synteny, QTLs, SNPs, RNA-Seq, and gene expression, among others. The software features an ultra-fast graphics-rendering engine that can load and visualize 30 million SNPs in 30 seconds in client-server installations. Persephone is a trademark of Ceres, Inc.

About Ceres

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company also licenses its genetics technology, software and biotech traits to other organizations.

Ceres Forward-Looking Statements

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Andre Franco, General Manager of Ceres Sementes do Brasil, indicated that embracing innovations has been the cornerstone of Brazil's success in agricultural commodities. In this case, Brazil can not only adopt new technologies, but also take the lead in developing them domestically.

"Increasing yields and providing greater yield stability from season to season represents a key opportunity for Brazil to strengthen its global position in sugar and ethanol production," said Franco. "We look forward to working with our mill customers and other industry leaders to evaluate and bring new products to market that can increase efficiencies and lower the cost of production."

The PAISS project is jointly managed by Brazil's national development bank, BNDES, and by the government's research financing agency, FINEP. The competitive application process included over 60 proposals. Ceres was one of only five organizations to be selected for both a loan and a grant.

ABOUT CERES

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations.

CERES FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from our plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand. The company also licenses its technology and biotech traits to other organizations. Persephone is a trademark of Ceres, Inc.

Ceres Forward-Looking Statements

This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

SOURCE Ceres, Inc.


Quelle: PR Newswire

Hamilton noted that growers are facing increasing demand for food, feed, fiber and fuel as a result of rising global population and an expanding middle class in certain regions. "The need for technology improvements has become more pressing due to stresses from climate variability and competition for water resources," said Hamilton. "Agricultural biotechnology has and will continue to represent a significant source of innovation for increasing crop yields through improving performance of seeds."

The new patent for this invention was issued by the U.S. Patent and Trademark Office as U.S. Patent No. 9,024,004 and is titled, Sequence-Determined DNA Fragments Encoding Acetohydroxyacid Synthase Proteins. Ceres owns or maintains exclusive licensed rights to approximately 85 issued patents and numerous pending patent applications in the United States and in various foreign jurisdictions. A patent is an intellectual property right granted by a government to an inventor to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the invention when the patent is granted.

Soybean is one of the most valuable and widely planted row crops in the world. From 2003 to 2013, the number of acres planted increased 2.4% annually, to 275 million acres today, according to the Food and Agriculture Organization of the United Nations. Soybeans are used for oil, feed for livestock and aquaculture, as a biofuel feedstock and as a protein for the human diet.

About Ceres
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

Ceres Forward-Looking Statements
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

To view the original version on PR Newswire, visit:www.prnewswire.com/news-releases/...-in-soybean-300089077.html

SOURCE Ceres, Inc.

Copyright 2015 PR Newswire

ih.advfn.com/p.php?pid=nmona&article=67359955

Ceres Continues Realignment Toward Food and Feed Markets and Biotech Traits
Date : 06/19/2015 @ 7:45AM
Source : PR Newswire (US)
Stock : Ceres, Inc. (MM) (CERE)
Quote : 2.17  0.0 (0.00%) @ 8:10AM
          §
Ceres Continues Realignment Toward Food and Feed Markets and Biotech Traits
Print
Ceres, Inc. (MM) (NASDAQ:CERE)
Intraday Stock Chart

Today : Friday 19 June 2015
Click Here for more Ceres, Inc. (MM) Charts.

THOUSAND OAKS, Calif., June 19, 2015 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, today announced the continued realignment of its business to focus on food and forage opportunities and biotechnology traits for sugarcane and other crops. As part of the realignment, the company will restructure its Brazilian seed operations and is exploring discussions with additional local partners and collaborators to support the continued development and commercialization of its technology in Brazil.

Earlier this year, the company announced that due to the economic challenges faced by the Brazilian ethanol industry as well as changes in the global energy market, it had expanded the number of market opportunities available for its technology and products and began prioritizing its working capital in additional areas beyond Brazil. The company's current restructuring plan is intended to further align expenditures toward improved forages for dairy and meat production and biotech traits for sugarcane and other crops.

"These changes represent an important step in the transformation of our business as we refocus on our strengths in agricultural technology and direct our attention to markets being fueled by global prosperity growth," said Ceres President and CEO Richard Hamilton. He noted that bioenergy markets have continued to face serious near-term challenges due to low oil prices, the struggling Brazilian economy, delays in second generation refining technology and unfavorable government policies, among other headwinds. "If these challenges can be surmounted then I believe the market for bioenergy feedstocks can reemerge as a global opportunity for agricultural technology companies like Ceres."

Brazilian Operations
Ceres indicated that its Brazilian operations after implementation of the restructuring plan would be focused primarily on sorghum breeding and sugarcane. In particular, the company plans to expand its sugarcane trait development activities for the Brazilian sugarcane market, which Ceres expects to fund, in part, under a grant available from the Brazilian government.

"Given the economic climate in Brazil, and the time horizon needed to bring our top performing sorghum hybrids to market, we believe that the best path forward is to work with a more focused group of well-capitalized mills and collaborators," said Paul Kuc, Ceres Chief Financial Officer. "Moreover, our advances in sugarcane biotechnology and compelling field trial results are making Brazilian sugarcane a more attractive use of capital."

The realignment plan, which is expected to be substantially completed by October 31, 2015, includes, among other actions, a workforce reduction that will impact 14 positions in Brazil primarily related to administration, operations and manufacturing as well as 2 support positions in the United States. Ceres estimates that it will incur total charges of approximately $0.6 million over the next five months with respect to these workforce reductions in Brazil and the U.S., including $0.1 million in continuation of salary and benefits of certain employees until their work is completed and their positions are eliminated, and $0.5 million of one-time severance and other costs, all of which will be cash expenditures. The company expects to achieve additional cost reductions as part of the realignment, which may include additional workforce reductions. Once fully implemented, the company's realignment plan is expected to deliver cash savings of up to approximately $6.0 to $8.0 million in fiscal year 2016.

In addition to the realignment in Brazil, the company continues to evaluate options available for additional funding, including public or private debt or equity financings, collaborations, licensing arrangements, government programs, or the sale of intellectual property, technology or other assets.

About Ceres
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

Ceres Forward-Looking Statements
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's restructuring plan and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

To view the original version on PR Newswire, visit:www.prnewswire.com/news-releases/...tech-traits-300101836.html

SOURCE Ceres, Inc.

Copyright 2015 PR Newswire